Panion & Bf Biotech Inc.

Taiwan Stock Exchange 1760.TW

Panion & Bf Biotech Inc. Receivables for the year ending December 31, 2023: USD 11.30 M

Panion & Bf Biotech Inc. Receivables is USD 11.30 M for the year ending December 31, 2023, a -3.95% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Panion & Bf Biotech Inc. Receivables for the year ending December 31, 2022 was USD 11.77 M, a -10.27% change year over year.
Panion & Bf Biotech Inc. Receivables for the year ending December 31, 2021 was USD 13.11 M, a -18.04% change year over year.
Panion & Bf Biotech Inc. Receivables for the year ending December 31, 2020 was USD 16.00 M, a 24.40% change year over year.
Panion & Bf Biotech Inc. Receivables for the year ending December 31, 2019 was USD 12.86 M, a 15.69% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Taiwan Stock Exchange: 1760.TW

Panion & Bf Biotech Inc.

CEO	Mr. Tsung-Ming Chiang
IPO Date	Dec. 20, 2007
Location	Taiwan
Headquarters	Building F
Employees	321
Sector	Health Care
Industries Biotechnology Cosmetics Pharmaceuticals

Description

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. The company offers products in the areas of medical beauty, kidney, respiratory tract, gastrointestinal tract, and body and hair cleaning. It also provides oral drugs and topical preparations; hand and mechanical disinfection, body lotion, and skin disinfection products; and pet health products, including surgical and skin prescriptions. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.

Key trends

Past 5 years